Latest filing published 19 Jul 2017 for Aurinia Pharmaceuticals Inc., €3.1M.
Filing timeline
BuySaleInsider track record
venBio Global Strategic Fund, L.P.: trading record in brief
This profile gathers the share dealings of venBio Global Strategic Fund, L.P. in Aurinia Pharmaceuticals Inc. Between 29 March 2017 and 25 April 2017, the trades on record add up to 15 filings.
On the market, this insider has only sold: 15 sales, €27.1M in total.
The newest entry dates from 19 July 2017: an open-market sale of €3.1M, in Aurinia Pharmaceuticals Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to venBio Global Strategic Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 602,014 shares@ CA$7.4111.5% of flowCommon SharesTSXSEDI:3037677
- 106,904 shares@ CA$6.86351.9% of flowCommon SharesTSXSEDI:3037696
- 94,225 shares@ CA$6.96921.7% of flowCommon SharesTSXSEDI:3037681
- 540,026 shares@ CA$7.28510.2% of flowCommon SharesTSXSEDI:3037679
- 64,400 shares@ CA$6.79251.1% of flowCommon SharesTSXSEDI:3037697
- 193,000 shares@ CA$6.55633.3% of flowCommon SharesTSXSEDI:3037693
- 186,430 shares@ CA$6.97793.3% of flowCommon SharesTSXSEDI:3037704
- 24,092 shares@ CA$7.02520.4% of flowCommon SharesTSXSEDI:3037695
- 445,487 shares@ CA$7.22218.4% of flowCommon SharesTSXSEDI:3037694
- 2,069,959 shares@ CA$7.375938.0% of flowCommon SharesTSXSEDI:3037706
- 260,903 shares@ CA$6.91864.6% of flowCommon SharesTSXSEDI:3037689
- 246,587 shares@ CA$7.0374.5% of flowCommon SharesTSXSEDI:3037678
- 273,800 shares@ CA$6.84714.8% of flowCommon SharesTSXSEDI:3037702
- 173,375 shares@ CA$7.083.2% of flowCommon SharesTSXSEDI:3037680
- 176,320 shares@ CA$6.78833.1% of flowCommon SharesTSXSEDI:3037699
15 of 15 declarations
